Search by category - Any -Regulated informationInside informationNon-regulated information Search by year - Any -202620252024202320222021202020192018201720162015 2 August 2021 Update on Fire Incident at Biocartis Warehouse Non-regulated information 31 July 2021 Fire Incident at Biocartis Warehouse in Mechelen, Belgium Non-regulated information 11 May 2021 Biocartis Receives EUR 1.4m Grant to Support Development of New Idylla™ Technology to Unlock Potential in Molecular Surveillance Non-regulated information 4 May 2021 Biocartis Announces New Collaboration with AstraZeneca to Expand Availability of Idylla™ EGFR Biomarker Testing Among Patients with Lung Cancer Non-regulated information 20 April 2021 Biocartis Announces US FDA 510(k) submission of its Idylla™ MSI Test Non-regulated information 22 March 2021 Biocartis Launches Idylla™ GeneFusion Assay as Rapid Lab Workflow Solution for Gene Fusion Testing Non-regulated information 2 February 2021 New US Studies Demonstrate Idylla™ Allows Rapid First Assessment of Most Common EGFR Mutations Preceding NGS Non-regulated information 17 November 2020 Biocartis Announces Publication of Large Multi-Center Comparison Study with Idylla™ MSI Assay Showing Very Low Failure Rates and Excellent Concordance with Reference Methods Non-regulated information 16 November 2020 Biocartis Announces Ten Idylla™ Studies to be Published at Virtual AMP (US) Annual Meeting Non-regulated information 10 November 2020 Biocartis Announces CE-marking of its Fully Automated Idylla™ SARS-CoV-2 Test Non-regulated information Pagination First page « First Previous page ‹‹ Page 1 Page 2 Page 3 Current page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page ›› Last page Last »